Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Last week patent highlights (11-05-09):
1. DIASTEREOMERIC PEPTIDES FOR MODULATING T CELL IMMUNITY
2. PCSK9 PROTEINS, FRAGMENTS THEREOF AND METHODS OF MODULATING PCSK9 PHOSPHORYLATION AND LOW DENSITY LIPOPROTEIN (LDLR) DEGRADATION
3. Compositions and Methods For Preventing or Treating Feline Chronic Renal Failure
4. LONG LASTING NATRIURETIC PEPTIDE DERIVATIVES
5. CONTRACEPTIVE COMPOSITION - including an effective amount of a dendrimer compound including one or more naphthyl disulphonic acid surface groups
6. USE OF THYMOSIN ALPHA 1, ALONE OR IN COMBINATION WITH PTX3 OR GANCICLOVIR, FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION
7. METHOD FOR STIMULATING ANGIOGENESIS USING DKK2 AND COMPOSITION COMPRISING THE SAME
8. Compositions and Methods for Inducing or Inhibiting Activities of Selected Human Cells
9. ANALOGS OF GHRELIN SUBSTITUTED AT THE N-TERMINAL
10. COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
11. COMPOSITION AND METHOD FOR PREPARING PLASMINOGEN
12. USE OF CALMODULIN KINASE II INHIBITORS TO TREAT OR PREVENT HEART MUSCLE INFLAMMATION
13. 2-HYDROXY-2-PHENYLTHIOPHENYLPROPIONAMIDES AS ANDROGEN RECEPTOR MODULATORS
14. COMPOUNDS AND METHOD FOR MODULATING INFLAMMATORY REACTIONS
15. G-CSF POLYPEPTIDES AND USES THEREOF - G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects
16. G-CSF POLYPEPTIDES AND USES THEREOF - G-CSF polypeptides and their uses, particularly for therapeutic or prophylactic treatment in human subjects
17. Therapeutic peptidomimetic macrocycles - biologically active peptidomimetic macrocycles for the treatment of cell proliferative disorders such as cancer
18. MUCIN HYPERSECRETION INHIBITORS AND METHODS OF USE
19. Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
20. Novel Compounds - pharmaceutical compositions comprising the same use of said compounds for the manufacture of a medicament for treatment of inter alia
21. Spirocyclic nitriles as protease inhibitors
22. NOVEL HYPOCHOLESTEROLEMIC COMPOUNDS - of formula useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels
23. USE OF A LACTOSE-DERIVED C-GLYCOSIDE COMPOUND AS AN AGENT FOR ACTIVATING AND REGULATING CUTANEOUS IMMUNITY
24. Mucoadhesive nanoparticles for cancer treatment
25. SKIN AGING TREATMENT COMPRISING PAEONIFLORIN
26. ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS
27. METHOD FOR IMPROVING CARDIOVASCULAR RISK PROFILE OF COX INHIBITORS
28. Gastric Raft Composition Comprising Preferably Processed Starches For Inducing Satiety
29. Method for producing starch networks and initial products
30. COSMETIC COMPOSITION COMPRISING AN OIL - cosmetic composition for making up or caring for the skin in the form of a water-in-oil emulsion comprising an
31. FUSED BICYCLIC PYRIMIDINE COMPOUNDS AS AURORA KINASE INHIBITORS
32. NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF
33. ANTIVIRAL PHOSPHONATE ANALOGS - The invention is related to phosphorus substituted compounds with antiviral activity compositions containing such
34. Antibacterial Agents - Described herein are antibacterial compounds methods for making the compounds pharmaceutical compositions containing the
35. Certain chemical entities, compositions, and methods
36. ARYLMETHYLIDENE HETEROCYCLES AS NOVEL ANALGESICS
37. Nuclear Transcription Factors Regulators
38. Pre-Compacted Calcium-Containing Compositions
39. Method for treating neurocognitive dysfunction
40. AZAHETEROCYCLYL DERIVATIVES OF ANDROSTANES AND ANDROSTENES AS MEDICAMENTS FOR CARDIOVASCULAR DISORDERS
41. Modified Glycosaminoglycans, Pharmaceutical Compositions and Methods for Oral Delivery Thereof
42. Method and kit for reducing the symptoms of peripheral vascular disease
43. Medicinal targeted local lipolysis - Aqueous phospholipid systems comprising at least one phospholipid at least one bile acid and water are suitable for
44. Diagnostic tests and personalized treatment regimes for cancer stem cells
45. METAL COMPLEX PHOSPHATIDYL-INOSITOL-3-KINASE INHIBITORS
46. COMPOUNDS AND METHODS FOR ACTIVATED THERAPY
47. USE OF PICOPLATIN TO TREAT COLORECTAL CANCER
48. Pyridyl Amide T-Type Calcium Channel Antagonists
49. Fluvastatin for the treatment of patients with a history of muscle related side effects with other statins
50. Therapy for Treating Resistant Bacterial Infections
51. DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
52. AMINOCARBOXYLIC ACID DERIVATIVE AND MEDICINAL USE THEREOF
53. Substituted indole ligands for the ORL-1 receptor
54. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
55. Novel Composition for Treatment of Diseases Related to Activated Lymphocytes
56. SUBSTITUTED SULFONAMIDE COMPOUNDS - corresponding to formula I STR00001 processes for the preparation thereof
57. Chronotherapeutic formulations of modified-release calcium channel blocker anti-hypertensive drugs in combination with other anti-hypertensive drugs for 24-hour optimal treatment of hypertension, nocturnal hypertension, and/or hypertension with angina
58. ORGANIC COMPOUNDS - which have interesting pharmaceutical properties
59. Compounds for the Treatment of Hepatitis C
60. TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE BY USING THEM IN COMBINATION
61. Combination of 5-HT7 Receptor Antagonist and Serotonin Reuptake Inhibitor Therapy
62. HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
63. Substituted aralkyl derivatives - novel substituted aralkyl derivatives of the general formula and their derivatives
64. BACE INHIBITORS - of Formula I: STR00001 methods for their use and intermediates and methods for their preparation
65. 2-HETEROCYCLOAMINO-4-IMIDAZOLYLPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION
66. FUSED QUINOLINE DERIVATIVE AND USE THEREOF
67. Benzotriazine Inhibitors of Kinases - The invention provides benzotriazine compounds having formula
68. SUBSTITUTED HETEROCYCLES AND THEIR USE AS CHK1, PDK1 AND PAK INHIBITORS
69. MORPHOLINYL AND PYRROLIDINYL ANALOGS - morpholinyl and pyrrolidinyl analogs pharmaceutical compositions containing them
70. FAB I INHIBITORS - Compounds of the formula are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections
71. Imidazolidinone Derivatives as 11B-HSD1 Inhibitors
72. NOVEL COMPOUNDS-300 - Compounds of Formula I, or pharmaceutically acceptable salts thereof: STR00001 wherein R
73. BENZOPHENONE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE
74. 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO[4,5-B]INDOLE-1-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE
75. IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS
76. Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
77. 3-SPIROINDOLIN-2-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
78. 3-SPIROINDOLIN-2-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
79. RENIN INHIBITORS - Disclosed are compounds according to Formula I: STR00001 wherein the variables are defined herein
80. Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
81. ANTIVIRAL COMPOUNDS AND USE THEREOF - compounds, pharmaceutical compositions and methods useful for treating viral infection
82. BIOCIDAL COMBINATIONS COMPRISING IMAZALIL
83. Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition
84. HETEROCYCLIC INHIBITORS OF PDE4 - potent and selective heterocyclic compounds useful as inhibitors of phosphodiesterase 4
85. METHODS OF TREATING ISCHEMIC RELATED CONDITIONS
86. NOVEL SULFONAMIDE COMPOUNDS - and their use as orexin receptor antagonists
87. Pyridazine Compound and Use Thereof - pyridazine compound of the formula: STR00001 has an excellent plant disease controlling effect
88. (1-AZINONE)-SUBSTITUTED PYRIDOINDOLES - Substituted pyridoindoles for incorporation in pharmaceutical compositions employed in the treatment of various
89. 1-HETEROCYCLYLSULFONYL, 2-AMINOMETHYL, 5- (HETERO-) ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITOR
90. Heterocyclic modulators of PKB - heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B
91. 3 Substituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors
92. 3-HYDRAZONE PIPERAZINYL RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS
93. METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE
94. Treatment of Neurodegenerative Disorders with Thiourea Compounds
95. METHODS OF TREATING CNS DISORDERS - methods of treating various CNS disorders, e
96. Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
97. THERAPEUTIC OR PROPHYLACTIC AGENT FOR MULTIPLE SCLEROSIS
98. MODIFIED PYRIMIDINE GLUCOCORTICOID RECEPTOR MODULATORS
99. Novel Pyriproxyfen Compositions - New pesticidal compositions comprising pyriproxyfen and methyl esters of C
100. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
previous page next page
Archives
09-04-08 07-02-09 10-16-08 05-28-09 12-25-08 10-01-09 09-11-08 07-09-09 02-26-09 08-13-0911-20-08 07-30-09 12-18-08 09-10-09 11-27-08 04-16-09 06-11-09 01-08-09 05-14-09 11-06-08
08-27-09 09-24-09 10-15-09 06-18-09 09-17-09 03-26-09 01-15-09 10-30-08 06-25-09 12-04-08
10-08-09 08-06-09 02-19-09 06-04-09 10-23-08 02-12-09 04-23-09 09-25-08 05-21-09 01-29-09
03-05-09 12-11-08 03-19-09 04-30-09 01-01-09 10-22-09 10-29-09 07-23-09 07-16-09 05-07-09
02-05-09 03-12-09 10-02-08 04-09-09 09-03-09 08-20-09 04-02-09 10-09-08 11-13-08 01-22-09
08-28-08 09-18-08 08-21-08